Immuneed
Select the most promising drug candidates with us and accelerate your path to drug development.
Select the most promising drug candidates with us and accelerate your path to drug development.
Immuneed is a biotechnology startup based in Sweden, founded in 2014 with the slogan "Select the most promising drug candidates with us and accelerate your path to drug development." The company specializes in enabling firms at the forefront of science to invest in the right drug candidate. Immuneed's unique ex-vivo test system ID.Flow, combined with a highly competent team, provides exclusive insights into the safety of their clients' most promising drug candidates. Their last investment round, a kr4.30M Seed Round, was secured on 13 September 2016 with Almi Invest being the investor. The startup operates within the Biotechnology, Health Care, and Pharmaceutical industries. Immuneed's capabilities in identifying the safest and most promising drug candidates make it an attractive prospect for venture capital investment.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | kr4.30M | 1 |
|
13 Sep 2016 |
No recent news or press coverage available for Immuneed.
We care about your data, and we'd love to use cookies make your experience better.
